EXEL
EXELIXIS, INC.
EXELIXIS, INC. (EXEL) has 17 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 3, 2026.
Insiders have net sold $3.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Michael Morrissey
- Employees:1,147
- HQ:Alameda, CA, US
- IPO:2000-04-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$14.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
WYSZOMIERSKI JACK LFirst filing | Director | Sale | 3,925 | $198K | Jun 3 | SEC ↗ |
Eckhardt Sue GailFirst filing | Director | Sale | 9,812 | $492K | Jun 3 | SEC ↗ |
Senner Christopher J.First filing | EVP and CFO | Sale | 34,901 | $1.7M | May 19 | SEC ↗ |
Hefti BrendaFirst filing | SVP and General Counsel | Sale | 6,625 | $333K | May 19 | SEC ↗ |
Beckerle Mary CFirst filing | Director | Sale | 7,712 | $374K | May 8 | SEC ↗ |
Related companies
EXELIXIS, INC. is in the Healthcare sector.